Drive growth through Portfolio Development & Commercialisation Cross-functional portfolio leadership in how we source, discover, develop and drive demand for our life-changing medicines Create value through operational excellence Operational excellence across our network, undisputed end-to-end plasma leadership and accelerating enterprise initiatives to unlock value Enable our people and partners to deliver the company’s future Agile & empowered employees living our values, hand-in-hand with trusted partners, supported by business-focused enabling functions and transformative digital capabilities OUR FOCUS OUR AMBITIONS THERAPEUTIC AREAS Immunoglobulins Vaccines TO DELIVER THIS WE WILL: Patients Who need durable, effective treatment for, and protection from serious disease Diseases Where we have a fundamental advantage in understanding the disease and science Medicines With a high degree of specialist expertise of manufacturing differentiation Cardiovascular & Renal Transplant & Immunology Haematology 11 CSL Limited Annual Report 2024/25
RkJQdWJsaXNoZXIy MjE2NDg3